Publications
- Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Pilot study on microRNAs as biomarkers of response to sunitinib treatment in patients with metastatic renal cell carcinoma2018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Candidate MicroRNA biomarkers of therapeutic response to sunitinib in metastatic renal cell carcinoma: A validation study in patients with extremely good and poor response2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Nivolumab induced encephalopathy in a man with metastatic renal celll cancer: a case report2018 | Faculty of Medicine in Hradec Králové
- Current possibilities of immunotherapy in the treatment of malignant melanoma2018 | Faculty of Medicine in Hradec Králové
- Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Immunoterapy related toxicities2017 | Faculty of Medicine in Hradec Králové
- Microsatellite instability as a predictive factor for immunotherapy in malignant melanoma2016 | Faculty of Medicine in Hradec Králové
Loading network view...